Xometry (NASDAQ:XMTR) CTO Sells $198,607.68 in Stock

Xometry, Inc. (NASDAQ:XMTR) CTO Vaidyanathan Raghavan sold 4,572 shares of the firm’s stock in a transaction on Thursday, February 26th. The stock was sold at an average price of $43.44, for a total value of $198,607.68. Following the completion of the sale, the chief technology officer directly owned 64,304 shares of the company’s stock, valued at approximately $2,793,365.76. This trade represents a 6.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Vaidyanathan Raghavan also recently made the following trade(s):

• On Monday, January 5th, Vaidyanathan Raghavan sold 3,570 shares of Xometry stock. The stock was sold at an average price of $66.51, for a total value of $237,440.70.

Xometry Trading Down 9.4%

Shares of NASDAQ XMTR opened at $41.01 on Friday. The company has a current ratio of 3.76, a quick ratio of 3.58 and a debt-to-equity ratio of 1.18. Xometry, Inc. has a one year low of $18.59 and a one year high of $73.87. The business has a 50-day moving average price of $60.65 and a two-hundred day moving average price of $56.08. The firm has a market capitalization of $2.10 billion, a PE ratio of -33.61 and a beta of 0.86.

Xometry (NASDAQ:XMTR) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.04. The business had revenue of $192.40 million during the quarter, compared to analyst estimates of $183.37 million. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The firm’s revenue was up 29.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.06 earnings per share. As a group, analysts predict that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Key Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Company delivered a solid quarter — revenue grew ~29.5% year‑over‑year and Q4 EPS beat consensus, supporting the long‑term growth story. Read More.
• Positive Sentiment: Management will attend investor conferences (including a March 3 fireside chat), giving investors more access to management and clarity on the upcoming CEO transition. Read More.
• Positive Sentiment: Some firms remain constructive — Citigroup and Wedbush kept buy/outperform stances even while trimming targets, which preserves upside conviction among bullish investors. Read More.
• Neutral Sentiment: A number of analysts adjusted targets with mixed tones — UBS and Royal Bank of Canada moved to neutral/sector‑perform levels, trimming upside but not issuing outright sell calls. This reduces short‑term consensus upside but isn’t uniformly bearish. Read More.
• Neutral Sentiment: Institutional ownership is very high (~97%), so large insider transactions and analyst flows can disproportionately influence intraday liquidity and volatility. Read More.
• Negative Sentiment: Significant, contemporaneous insider selling — CEO, CFO, President, CTO and other insiders reported multi‑thousand‑share sales on Feb. 26. Heavy insider sales on the same day typically spook investors and add downward pressure. Read More.
• Negative Sentiment: Analyst downgrades and target cuts triggered selling flow — several outlets reported the stock drifting lower after the analyst actions, which appears to be a primary catalyst for today’s weakness. Read More.
• Negative Sentiment: Conflicting narratives around the earnings release (some headlines emphasizing the beat, others highlighting margin/negative net income issues) increase short‑term uncertainty and volatility. Read More.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Xometry in a research note on Wednesday, January 21st. Cantor Fitzgerald upped their target price on Xometry from $41.00 to $60.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Wedbush cut their price target on Xometry from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Wednesday. Citizens Jmp set a $75.00 price target on Xometry in a report on Wednesday, November 5th. Finally, William Blair restated an “outperform” rating on shares of Xometry in a report on Tuesday. Five equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Xometry has an average rating of “Hold” and an average target price of $62.00.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in XMTR. Sylebra Capital LLC lifted its holdings in Xometry by 9.6% in the 2nd quarter. Sylebra Capital LLC now owns 2,062,157 shares of the company’s stock worth $69,680,000 after purchasing an additional 180,533 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Xometry by 54.2% during the third quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company’s stock valued at $107,029,000 after purchasing an additional 690,558 shares during the last quarter. First Trust Advisors LP raised its position in shares of Xometry by 9.2% in the fourth quarter. First Trust Advisors LP now owns 1,576,075 shares of the company’s stock valued at $93,729,000 after purchasing an additional 132,792 shares during the period. Baillie Gifford & Co. lifted its stake in shares of Xometry by 1.6% in the fourth quarter. Baillie Gifford & Co. now owns 1,306,151 shares of the company’s stock worth $77,677,000 after buying an additional 20,901 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Xometry in the fourth quarter worth $76,393,000. Institutional investors and hedge funds own 97.31% of the company’s stock.

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.